FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105403730> ?p ?o ?g. }

• W2105403730 endingPage "1328" @default.
• W2105403730 startingPage "1320" @default.
• W2105403730 abstract "Reactivation of hepatitis is one of the most serious complications of chemotherapy in lymphoma patients who are carriers of the hepatitis B virus (HBV). Glucocorticoids are linked to increased risk of HBV reactivation. This study seeks to clarify whether removal of glucocorticoids from chemotherapy regimens may decrease the risk of HBV reactivation. Eligible patients were seropositive for hepatitis B surface antigen (HBsAg) and had histologically proven non-Hodgkin's lymphomas for which intensive chemotherapy was indicated. Patients were randomized to receive either ACE (epirubicin, cyclophosphamide, and etoposide) or PACE (prednisolone + ACE). A total of 50 patients were enrolled, 25 each for the ACE and PACE arms. The cumulative incidence of HBV reactivation at 9 months after starting chemotherapy was 38% and 73% for ACE and PACE arm, respectively (P =.03). The degree of clinical hepatitis was significantly more severe in the PACE arm: 11 patients (44%) in the PACE and 3 patients (13%) in the ACE arm had ALT elevation more than 10-fold of normal (P =.025), and 7 patients (28%) in the PACE and 1 patient (4%) in the ACE arm had icteric hepatitis (P =.049). Complete remission of tumors occurred in 11 (46%) patients in the PACE and 8 (35%) patients in the ACE arm (P =.556). The estimated overall survival rate at 46 months was 68% in the PACE arm and 36% in the ACE arm, respectively (P =.18). In conclusion, steroid-free chemotherapy decreases the incidence and severity of HBV reactivation in HBsAg-positive lymphoma patients. However, further research is needed to evaluate whether steroid-free chemotherapy may confer a less satisfactory control of lymphoma." @default.
• W2105403730 created "2016-06-24" @default.
• W2105403730 creator A5005769924 @default.
• W2105403730 creator A5007004865 @default.
• W2105403730 creator A5014314211 @default.
• W2105403730 creator A5014734397 @default.
• W2105403730 creator A5016184067 @default.
• W2105403730 creator A5017953971 @default.
• W2105403730 creator A5032738660 @default.
• W2105403730 creator A5033189668 @default.
• W2105403730 creator A5058253583 @default.
• W2105403730 creator A5058608094 @default.
• W2105403730 creator A5064923841 @default.
• W2105403730 creator A5086791107 @default.
• W2105403730 creator A5090591171 @default.
• W2105403730 date "2003-06-01" @default.
• W2105403730 modified "2023-10-01" @default.
• W2105403730 title "Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma" @default.
• W2105403730 cites W1501675342 @default.
• W2105403730 cites W1610454879 @default.
• W2105403730 cites W1750231583 @default.
• W2105403730 cites W1813391014 @default.
• W2105403730 cites W1844155670 @default.
• W2105403730 cites W1975358575 @default.
• W2105403730 cites W1977520603 @default.
• W2105403730 cites W1981567928 @default.
• W2105403730 cites W1983718767 @default.
• W2105403730 cites W1989712687 @default.
• W2105403730 cites W1990335264 @default.
• W2105403730 cites W2006226407 @default.
• W2105403730 cites W2016000559 @default.
• W2105403730 cites W2021894610 @default.
• W2105403730 cites W2033146500 @default.
• W2105403730 cites W2040719842 @default.
• W2105403730 cites W2042743169 @default.
• W2105403730 cites W2063041472 @default.
• W2105403730 cites W2065598785 @default.
• W2105403730 cites W2072210000 @default.
• W2105403730 cites W2081933606 @default.
• W2105403730 cites W2091699551 @default.
• W2105403730 cites W2098555404 @default.
• W2105403730 cites W2143345692 @default.
• W2105403730 cites W2147406474 @default.
• W2105403730 cites W2159954626 @default.
• W2105403730 cites W2258868118 @default.
• W2105403730 cites W2979890205 @default.
• W2105403730 cites W4243021776 @default.
• W2105403730 cites W56605606 @default.
• W2105403730 doi "https://doi.org/10.1053/jhep.2003.50220" @default.
• W2105403730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12774010" @default.
• W2105403730 hasPublicationYear "2003" @default.
• W2105403730 type Work @default.
• W2105403730 sameAs 2105403730 @default.
• W2105403730 citedByCount "256" @default.
• W2105403730 countsByYear W21054037302012 @default.
• W2105403730 countsByYear W21054037302013 @default.
• W2105403730 countsByYear W21054037302014 @default.
• W2105403730 countsByYear W21054037302015 @default.
• W2105403730 countsByYear W21054037302016 @default.
• W2105403730 countsByYear W21054037302017 @default.
• W2105403730 countsByYear W21054037302018 @default.
• W2105403730 countsByYear W21054037302019 @default.
• W2105403730 countsByYear W21054037302020 @default.
• W2105403730 countsByYear W21054037302021 @default.
• W2105403730 countsByYear W21054037302022 @default.
• W2105403730 countsByYear W21054037302023 @default.
• W2105403730 crossrefType "journal-article" @default.
• W2105403730 hasAuthorship W2105403730A5005769924 @default.
• W2105403730 hasAuthorship W2105403730A5007004865 @default.
• W2105403730 hasAuthorship W2105403730A5014314211 @default.
• W2105403730 hasAuthorship W2105403730A5014734397 @default.
• W2105403730 hasAuthorship W2105403730A5016184067 @default.
• W2105403730 hasAuthorship W2105403730A5017953971 @default.
• W2105403730 hasAuthorship W2105403730A5032738660 @default.
• W2105403730 hasAuthorship W2105403730A5033189668 @default.
• W2105403730 hasAuthorship W2105403730A5058253583 @default.
• W2105403730 hasAuthorship W2105403730A5058608094 @default.
• W2105403730 hasAuthorship W2105403730A5064923841 @default.
• W2105403730 hasAuthorship W2105403730A5086791107 @default.
• W2105403730 hasAuthorship W2105403730A5090591171 @default.
• W2105403730 hasBestOaLocation W21054037301 @default.
• W2105403730 hasConcept C126322002 @default.
• W2105403730 hasConcept C203014093 @default.
• W2105403730 hasConcept C2522874641 @default.
• W2105403730 hasConcept C2775940106 @default.
• W2105403730 hasConcept C2776029263 @default.
• W2105403730 hasConcept C2776694085 @default.
• W2105403730 hasConcept C2776715498 @default.
• W2105403730 hasConcept C2776755627 @default.
• W2105403730 hasConcept C2777382497 @default.
• W2105403730 hasConcept C2777410769 @default.
• W2105403730 hasConcept C2780593183 @default.
• W2105403730 hasConcept C2780835546 @default.
• W2105403730 hasConcept C71924100 @default.
• W2105403730 hasConcept C90924648 @default.
• W2105403730 hasConceptScore W2105403730C126322002 @default.
• W2105403730 hasConceptScore W2105403730C203014093 @default.
• W2105403730 hasConceptScore W2105403730C2522874641 @default.

• next